Portaria conjunta nº 11, de 2 de julho de 2021

Simple item page
dc.TypeRevistas/Boletinspt_BR
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva
dc.contributor.authorInstituto Nacional de Câncer (Brasil)
dc.contributor.authorINCA
dc.contributor.authorSistema Único de Saúde (Brasil)
dc.contributor.authorBrasil. Ministério da Saúde
dc.date.accessioned2021-08-31T17:35:10Z
dc.date.available2021-08-31T17:35:10Z
dc.date.issued2021-07
dc.description3 p.: il. p&b.
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3817
dc.language.isoportpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno V, n. 50.
dc.subjectLeucemia Linfoblástica Agudapt_BR
dc.subjectMesilato de Imatinibpt_BR
dc.subjectNeoplasiaspt_BR
dc.subjectImatinib Mesylate
dc.subjectLeucemia-Linfoma Linfoblástico de Células Precursoras
dc.subjectPrecursor Cell Lymphoblastic Leukemia-Lymphoma
dc.subjectNeoplasms
dc.titlePortaria conjunta nº 11, de 2 de julho de 2021pt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
informe-sus-onco-julho-2021_0.pdf
Size:
571.74 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Informe SUS - ONCO 2021